About Technology Issues FAQ

Links

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study

Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.